These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 29525760)
1. Pancytopenia: a rare complication of Graves' disease. Garla VV; Abdul Salim S; Yanes-Cardozo LL BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29525760 [TBL] [Abstract][Full Text] [Related]
2. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report. Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843 [TBL] [Abstract][Full Text] [Related]
3. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report. Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094 [TBL] [Abstract][Full Text] [Related]
4. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575 [TBL] [Abstract][Full Text] [Related]
5. Clinical features of primary hyperthyroidism caused by Graves' disease admixed with resistance to thyroid hormone (P453T). Sato H Endocr J; 2010; 57(8):687-92. PubMed ID: 20574139 [TBL] [Abstract][Full Text] [Related]
6. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease. Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084 [TBL] [Abstract][Full Text] [Related]
7. [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs]. Wu G; Jie Y; Situ Y Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):274-5. PubMed ID: 11798886 [TBL] [Abstract][Full Text] [Related]
8. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy. Ueta Y; Fukui H; Murakami H; Yamanouchi Y; Yamamoto R; Murao A; Santou Y; Taniguchi S; Mitani Y; Shigemasa C Thyroid; 1999 Feb; 9(2):179-82. PubMed ID: 10090319 [TBL] [Abstract][Full Text] [Related]
9. A case of pulmonary metastatic thyroid cancer complicated with Graves' disease. Suzuki K; Nakagawa O; Aizawa Y Endocr J; 2001 Apr; 48(2):175-9. PubMed ID: 11456264 [TBL] [Abstract][Full Text] [Related]
10. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease. Choo YK; Yoo WS; Kim DW; Chung HK Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556 [TBL] [Abstract][Full Text] [Related]
11. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy. Laurberg P; Berman DC; Andersen S; Bülow Pedersen I Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677 [TBL] [Abstract][Full Text] [Related]
12. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. Nachum Z; Rakover Y; Weiner E; Shalev E Am J Obstet Gynecol; 2003 Jul; 189(1):159-65. PubMed ID: 12861156 [TBL] [Abstract][Full Text] [Related]
13. Valuable predictive features of relapse of Graves' disease after antithyroid drug treatment. Liu X; Shi B; Li H Ann Endocrinol (Paris); 2015 Dec; 76(6):679-83. PubMed ID: 26514949 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose. Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020 [TBL] [Abstract][Full Text] [Related]
15. Neonatal hyperthyroidism in infants of mothers previously thyroidectomized due to Graves' disease. Borrás-Pérez MV; Moreno-Pérez D; Zuasnabar-Cotro A; López-Siguero JP J Pediatr Endocrinol Metab; 2001; 14(8):1169-72. PubMed ID: 11592578 [TBL] [Abstract][Full Text] [Related]
16. Graves' disease in two pregnancies complicated by fetal goitrous hypothyroidism: successful in utero treatment with levothyroxine. Bliddal S; Rasmussen ÅK; Sundberg K; Brocks V; Skovbo P; Feldt-Rasmussen U Thyroid; 2011 Jan; 21(1):75-81. PubMed ID: 21162688 [TBL] [Abstract][Full Text] [Related]
17. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment. Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255 [TBL] [Abstract][Full Text] [Related]
18. Graves' hyperthyroidism-related pancytopenia: a case report with literature review. Scappaticcio L; Bellastella G; Maiorino MI; Longo M; Catalano C; Esposito K; Paolisso G; Rizzo MR Hormones (Athens); 2021 Mar; 20(1):93-100. PubMed ID: 32638234 [TBL] [Abstract][Full Text] [Related]
19. Thyrotoxic hypokalaemic periodic paralysis: a rare presentation of Graves' disease in a Hispanic patient. Matta A; Koppala J; Gossman W BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24717588 [TBL] [Abstract][Full Text] [Related]
20. Pancytopenia in untreated patients with Graves' disease. Lima CS; Zantut Wittmann DE; Castro V; Tambascia MA; Lorand-Metze I; Saad ST; Costa FF Thyroid; 2006 Apr; 16(4):403-9. PubMed ID: 16646688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]